LEN
50
-2
NOV
52
-5
SEE
53
3
NAVI
52
-2
RIG
43
-7
EXR
57
2
XYL
35
-2
EXC
54
3
MCHP
34
-2
LH
40
-5
SNA
70
-5
LUV
45
-2
GIS
22
-4
TEL
60
-8
SYY
49
9
CL
54
3
EW
32
3
CAH
48
-6
UPS
48
2
JNPR
50
-6
LEN
50
-2
NOV
52
-5
SEE
53
3
NAVI
52
-2
RIG
43
-7
EXR
57
2
XYL
35
-2
EXC
54
3
MCHP
34
-2
LH
40
-5
SNA
70
-5
LUV
45
-2
GIS
22
-4
TEL
60
-8
SYY
49
9
CL
54
3
EW
32
3
CAH
48
-6
UPS
48
2
JNPR
50
-6
Financhill
Back

Franklin Intl Core Div Tlt Idx ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
58

DIVI
Franklin Intl Core Div Tlt Idx ETF

Last Price:
30.50
Seasonality Move:
1.25%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
58
Franklin Intl Core Div Tlt Idx ETF (DIVI) is a Buy

Is Franklin Intl Core Div Tlt Idx ETF a Buy, Sell or Hold?

  • The current Franklin Intl Core Div Tlt Idx ETF [DIVI] share price is $30.52. The Score for DIVI is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • DIVI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DIVI Stock Price Chart

What is Franklin Intl Core Div Tlt Idx ETF's stock price today?

  • The Franklin Intl Core Div Tlt Idx ETF share price today is $30.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DIVI is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DIVI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 32.77 Sell
Chaikin Money Flow: 42568 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.02 - 32.14) Sell
Bollinger Bands (100): (31.29 - 32.81) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DIVI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.96 Sell
20-day SMA: 31.4 Sell
50-day SMA: 32.16 Sell
200-day SMA: 31.91 Sell
8-day EMA: 30.89 Sell
20-day EMA: 31.35 Sell
50-day EMA: 31.83 Sell
200-day EMA: 31.59 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Franklin Intl Core Div Tlt Idx ETF Earnings Growth & DIVI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Franklin Intl Core Div Tlt Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):